Abbonarsi

A heterogeneous subtype of biliary epithelial senescence may be involved in the pathogenesis of primary biliary cholangitis - 13/12/24

Doi : 10.1016/j.clinre.2024.102512 
Motoko Sasaki a, , Yasunori Sato a, Yasuni Nakanuma b
a Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, 920-8640, Japan 
b Department of Pathology, Fukui Saiseikai Hospital, Fukui 918-8503, Japan 

Corresponding author at: Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa 920-8640, Japan.Department of Human PathologyKanazawa University Graduate School of MedicineKanazawa920-8640Japan

Highlights

PD-L1 expression was increased in the damaged small bile ducts in PBC.
STING expression was increased in small bile ducts and ductular reactions in PBC.
PD-L1 and STING expression was significantly increased in cultured senescent BECs.
Senescent BECs with PD-L1 expression may be involved in the pathogenesis of PBC.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background & aims

Biliary epithelial senescence is involved in the pathogenesis of primary biliary cholangitis (PBC). We hypothesized that a unique subtype of programmed death-ligand 1 (PD-L1)-positive senescent biliary epithelial cells (BECs) may be related to the pathogenesis of PBC in association with cyclic GMP-AMP synthase (cGAS)- stimulator of interferon genes (STING) pathway.

Approach & results

The expression of PD-L1, STING and their association with senescent markers p16INK4a and p21WAF1/Cip1 were immunohistochemically determined in livers taken from the patients with PBC (n = 87) and 97 diseased and normal control livers. The expression of PD-L1 was significantly increased in a part of senescent BECs with p21WAF1/Cip1 expression in BECs in the damaged small bile ducts in PBC, compared to control livers (p < 0.01). In contrast, PD-L1 was not expressed in BECs in ductular reactions. The expression of STING was significantly increased in BECs in small bile ducts and ductular reactions in PBC, compared to control livers (p < 0.01). The expression of PD-L1, STING and senescence associated secretory phenotypes (SASPs) including interferon (IFN)-beta was significantly increased in senescent BECs induced by a treatment with serum depletion or glycochenodeoxycholic acid (GCDC) for 4–7 days (p < 0.01) and the increase was significantly suppressed by a knockdown of STING using siRNA (p < 0.01). Induction of cellular senescence induced by a treatment with serum depletion or GCDC was significantly suppressed by a knockdown of STING in BECs. (p < 0.01).

Conclusion

A unique subtype of senescent BECs with PD-L1 expression associated with cGAS-STING pathway may be involved in the pathogenesis of PBC.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Programmed death-ligand 1 (PD-L1), cGAS(cyclic GMP-AMP synthase)-STING(stimulator of interferon genes) pathway, Cellular senescence, Biliary epithelial cells, Primary biliary cholangitis


Mappa


© 2024  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 49 - N° 1

Articolo 102512- Gennaio 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Toward automated small bowel capsule endoscopy reporting using a summarizing machine learning algorithm: The SUM UP study
  • Charles Houdeville, Marc Souchaud, Romain Leenhardt, Lia CMJ Goltstein, Guillaume Velut, Hanneke Beaumont, Xavier Dray, Aymeric Histace
| Articolo seguente Articolo seguente
  • Primary hepatic large B-cell lymphoma
  • Dan-Lei Han, Jian Zha, Lin-Yan Wan, Wei Liu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.